Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis

被引:115
作者
Weide, B. [1 ]
Elsaesser, M. [1 ]
Buettner, P. [2 ]
Pflugfelder, A. [1 ]
Leiter, U. [1 ]
Eigentler, T. K. [1 ]
Bauer, J. [1 ]
Witte, M. [3 ]
Meier, F. [1 ]
Garbe, C. [1 ,2 ]
机构
[1] Univ Med Ctr, Ctr Dermatooncol, Dept Dermatol, D-72076 Tubingen, Germany
[2] James Cook Univ, Skin Canc Res Grp, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia
[3] Univ Med Ctr, Dept Gen & Transplant Surg, D-72076 Tubingen, Germany
关键词
lactate dehydrogenase; melanoma; metastasectomy; prognosis; S100; STAGE-IV-MELANOMA; AMERICAN JOINT COMMITTEE; ONCOLOGY-GROUP TRIALS; MALIGNANT-MELANOMA; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; GERMAN GUIDELINES; SURVIVAL; PROTEIN; S100-BETA;
D O I
10.1038/bjc.2012.306
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Established prognostic factors are of limited value to predict long-term survival and benefit from metastasectomy in advanced melanoma. This study aimed to identify prognostic factors in patients with distant metastasis. METHODS: We analysed overall survival of 855 institutional melanoma patients with distant metastasis by bivariate Kaplan-Meier survival probabilities and multivariate Cox hazard regression analysis. RESULTS: Serum lactate dehydrogenases (LDH), S100B, the interval between initial diagnosis and occurrence of distant metastasis, the site of distant metastases, and the number of involved distant sites were significant independent prognostic factors in both bivariate and multivariate analyses. Visceral metastases other than lung (hazard ratio (HR) 1.8), elevated S100B (HR 1.7) and elevated LDH (HR 1.6) had the highest negative impact on survival. Complete metastasectomy was likewise an independent prognostic factor in multivariate analysis. This treatment was associated with favourable survival for patients with normal LDH and S100B values (5-year survival, 37.2%). CONCLUSION: The serum markers LDH and S100B were both found to be prognostic factors in melanoma patients with distant metastasis. Furthermore, complete metastasectomy had an independent favourable prognostic impact in particular for the patient subgroup with normal LDH and S100B values. British Journal of Cancer (2012) 107, 422-428. doi: 10.1038/bjc.2012.306 www.bjcancer.com Published online 10 July 2012 (C) 2012 Cancer Research UK
引用
收藏
页码:422 / 428
页数:7
相关论文
共 37 条
[1]   S-100 PROTEIN NEGATIVE MALIGNANT-MELANOMA - FACT OR FICTION - A LIGHT-MICROSCOPIC AND IMMUNOHISTOCHEMICAL STUDY [J].
ARGENYI, ZB ;
CAIN, C ;
BROMLEY, C ;
VANNGUYEN, A ;
ABRAHAM, AA ;
KERSCHMANN, R ;
LEBOIT, PE .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1994, 16 (03) :233-240
[2]   Final Version of 2009 AJCC Melanoma Staging and Classification [J].
Balch, Charles M. ;
Gershenwald, Jeffrey E. ;
Soong, Seng-jaw ;
Thompson, John F. ;
Atkins, Michael B. ;
Byrd, David R. ;
Buzaid, Antonio C. ;
Cochran, Alistair J. ;
Coit, Daniel G. ;
Ding, Shouluan ;
Eggermont, Alexander M. ;
Flaherty, Keith T. ;
Gimotty, Phyllis A. ;
Kirkwood, John M. ;
McMasters, Kelly M. ;
Mihm, Martin C., Jr. ;
Morton, Donald L. ;
Ross, Merrick I. ;
Sober, Arthur J. ;
Sondak, Vernon K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6199-6206
[3]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[4]   S100-beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma [J].
Deichmann, M ;
Benner, A ;
Bock, M ;
Jäckel, A ;
Uhl, K ;
Waldmann, V ;
Näher, H .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1891-1896
[5]   S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles [J].
Donato, R .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (07) :637-668
[6]   Long-term survival analysis in metastatic melanoma: Serum S100B is an independent prognostic marker and superior to LDH [J].
Egberts, Friederike ;
Pollex, Andrea ;
Egberts, Jan-Hendrik ;
Kaehler, Katharina C. ;
Weichenthal, Michael ;
Hauschild, Axel .
ONKOLOGIE, 2008, 31 (07) :380-384
[7]   Contemporary surgical treatment of advanced-stage melanoma [J].
Essner, R ;
Lee, JH ;
Wanek, LA ;
Itakura, H ;
Morton, DL .
ARCHIVES OF SURGERY, 2004, 139 (09) :961-966
[8]   Prognostic factors for survival of patients treated systemically for disseminated melanoma [J].
Eton, O ;
Legha, SS ;
Moon, TE ;
Buzaid, AC ;
Papadopoulos, NE ;
Plager, C ;
Burgess, AM ;
Bedikian, AY ;
Ring, S ;
Dong, Q ;
Glassman, AB ;
Balch, CM ;
Benjamin, RS .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1103-1111
[9]  
FINCK SJ, 1983, CANCER-AM CANCER SOC, V51, P840, DOI 10.1002/1097-0142(19830301)51:5<840::AID-CNCR2820510516>3.0.CO
[10]  
2-7